Showing results (61-70 of 209) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Investigation|January 17, 2023
Impact of epigenetic reprogramming on antitumor immune responses in gliomaBrandon L McClellan, Santiago Haase, Felipe J Nunez, et al.
Current Topics in Medicinal Chemistry|October 27, 2005
Combining cytotoxic and immune-mediated gene therapy to treat brain tumorsJames F Curtin, Gwendalyn D King, Marianela Candolfi, et al.
Cancer Research|July 20, 2014
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunityGregory J Baker, Peter Chockley, Viveka Nand Yadav, et al.
Plos One|April 24, 2008
Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trialsJames F Curtin, Marianela Candolfi, Tamer M Fakhouri, et al.
Cancer Research|January 8, 2017
Mutated Chromatin Regulatory Factors as Tumor Drivers in CancerCarl Koschmann, Felipe J Nunez, Flor Mendez, et al.
Human Gene Therapy. Clinical Development|September 7, 2013
Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaNathan VanderVeen, Christopher Paran, Jonathan Krasinkiewicz, et al.
Nature Communications|November 11, 2020
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapyJason V Gregory, Padma Kadiyala, Robert Doherty, et al.
Brain Research Bulletin|October 16, 2009
Adenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changesMehrnoosh Saghizadeh, Andrei A Kramerov, Yousha Yaghoobzadeh, et al.
Pageof 21